Pharsight

1. List of Sotyktu drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE47929	BRISTOL	Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses	Nov, 2033 (10 years from now)
US10000480	BRISTOL	Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses	Nov, 2033 (10 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11021475	BRISTOL	Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses	Nov, 2033 (10 years from now)